Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mustang Bio Inc (NQ: MBIO )

0.5767 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.5767
Bid (Size) 0.5600 (100)
Ask (Size) 0.6900 (5)
Prev. Close 0.5767
Today's Range 0.5767 - 0.5767
52wk Range 0.5505 - 3.200
Shares Outstanding 100,287,838
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market cap stands at $14.0 million. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga

Performance

YTD
-68.14%
-68.14%
1 Month
-2.25%
-2.25%
3 Month
-45.08%
-45.08%
6 Month
-66.27%
-66.27%
1 Year
-81.52%
-81.52%

More News

Read More
Mustang Bio Shares Gain As FDA Grants Orphan Drug Status To Waldenstrom Drug
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Mustang Bio Posts Encouraging Interim Data From Gene Therapy Trial In Immunodeficiency
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Mustang Bio's CAR T Cell Therapy Shows Favorable Safety Profile, Response Rates In Blood Cancer Patients
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
63 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
Via Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
3 Penny Stocks Insiders Are Buying
Via Benzinga
Mustang Bio Secures $2M NIH Grant For CAR T Cell Therapy Development
Via Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Via Benzinga
Mustang Bio, Mayo Clinic Join Forces On New CAR T Tech In Tumor Settings
Via Benzinga
3 Penny Stocks Insiders Are Buying
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.